Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study-Reference-Cited by-同舟云学术

Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study

Published:2017-02-10 Issue:3 Volume:20 Page:420-428
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Forslund Tomas¹²,Wettermark Björn²³,Andersen Morten³,Hjemdahl Paul¹

Affiliation:

1. Clinical Epidemiology/Clinical Pharmacology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, SE-171 76 Stockholm, Sweden

2. Department of Healthcare Development, Stockholm County Council, Public Healthcare Services Committee, Karolinska University Hospital Solna, Stockholm, Sweden

3. Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/20/3/420/24186229/euw416.pdf

Reference16 articles.

1. Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA(2)DS(2)VASc scores: experience from the Stockholm region;Forslund;Eur J Clin Pharmacol,2014

2. Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system;Forslund;lnt J Cardiol,2013

3. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life;Cardiology;2024-08-01

2. Morbidity and hospitalisations among older adults with home care – a nationwide register study;2023-10-31

3. Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia;Frontiers in Pharmacology;2023-09-15

4. Mortality on DOACs Versus on Vitamin K Antagonists in Atrial Fibrillation: Analysis of the Hungarian Health Insurance Fund Database;Clinical Therapeutics;2023-04

5. Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants;American Journal of Kidney Diseases;2023-03